Anima cuts clinic call waits 75% with OpenAI's latest models

The 75% figure comes from Anima's own deployment with no third-party audit, no disclosed baseline call volume, and no clarity on whether the reduction reflects AI handling calls outright or simply routing them faster. Those are very different operational outcomes with very different labor implications.

The Shield story from October 23rd is the cleaner comparison here: Shield reported a 35-40% efficiency gain from Astra in IT workflows, a more modest number that came with at least some framing around what prior models achieved. Anima's 75% claim is nearly double that, in a higher-stakes domain, with less supporting context. The broader pattern across Uber's ChatGPT Work rollout and Amp's agent deployment is that real enterprise gains are real but tend to be incremental and workflow-specific. A 75% reduction in a patient-facing triage metric, if accurate, would be among the strongest ROI figures reported in this wave of deployments, which is exactly why the sourcing deserves more scrutiny than a partner case study published by the model vendor.

Watch whether Anima publishes an independent audit or peer-reviewed outcome study within the next six months. If the metric holds under external review with disclosed methodology, it becomes a credible benchmark for clinical AI deployment. If it stays confined to OpenAI's own case study library, treat it as a marketing data point.